BIOE 273 Biodesign for Mobile Health
NEW for Fall 2012: Undergraduate, graduate or postdoctoral students from the Schools of Medicine and Engineering are invited to participate in the Course BioE 273 (Fall).
This seminar examines the emerging Mobile Health industry. Mobile Health (mHealth, or, wireless health) is the provision of health services and information via mobile technologies such as mobile phones and wearable sensors. Innovations in this area promise solutions to the need for universal access to affordable and effective health care by enabling consumers to take charge of their health, creating affordable ways to manage aging and chronic conditions, moving care from the hospital into the home, improving treatment options by providing transparency of measurable clinical outcomes, and shifting the focus from “sick care” to “health improvement” and prevention.
Faculty from Stanford University and other Academic Institutions and guest lecturers from the Mobile Health industry and entrepreneurial community will discuss the driving needs, opportunities and challenges that characterize the emerging Mobile Health innovation landscape, and present an overview of the technologies, initiatives and companies that are already transforming the way we access health care today.
Mobile Health topics and perspectives covered include: Key Applications, Innovation for the Consumer and the Enterprise, Policy and Regulatory, Financing, Business Models, Global Initiatives and Entrepreneurship.
Goals for the Course
- Provide an overview of the emerging mobile health industry
- Explore selected applications and technologies
- Highlight interdependencies and synergies between shareholders
- Provide exposure to role models and industry experts who can help clarify career paths and inspire entrepreneurship opportunities in mobile health
Topics Covered
- Key Markets and Applications
- Enabling Technologies
- Regulatory and Policy
- Financing
- Global Initiatives
- Entrepreneurship
Student Responsibilities
The Biodesign for Mobile Health course is taught by a combination of Faculty from Stanford University and other Academic Institutions including UC Berkeley and USC Keck School of Medicine, and guest lecturers from the Mobile Health industry and entrepreneurial community.
As such, the course provides a unique opportunity to gain real-world insights and learn about opportunities for research and the creation of innovative solutions in the space.
Grading will be based on attendance and submission of a question for the guest speakers prior to each class session. Head count will be taken the first 15 minutes of class. Recommended readings are expected to be completed also prior to attending class, but not required.
Guest Speakers
The course is structured as a series of weekly lectures, which see the participation of several invited guests in panels of 4 speakers.
- Abhas Gupta, Associate at Mohr Davidow Ventures
- Dr. Adam Schlifke, Anesthesiologist, Health IT Leader, Kaiser Permanente and Mentor, Blueprint Health
- Adrian Aguilera, Assistant Professor, University of California Berkeley
- Alex Tam, Senior Interaction Designer, Frog Design
- Amar Kendale, Vice President of Strategy and Market Development, mc10 Inc.
- Amy Andersen, Practice Leader, Healthcare Payor & Provider Consulting, Booz Allen Hamilton
- Amy Lockwood, Deputy Director, Center for Innovation in Global Health, Stanford University School of Medicine
- Amy Tenderich, VP of Patient Advocacy, Alliance Health Networks & Editor, DiabetesMine.com
- Andrew Broderick, Research Program Director, Public Health Institute
- Anil Sethi, Board of Directors and Adjunct Professor, Johns Hopkins Medical School
- Arjun Rao, Manager, Clinical Effectiveness, Stanford Hospital & Clinics
- Dr. Arnold Milstein, Professor of Medicine, Stanford University & Director, Stanford CERC
- Ben Wilson, Director, Intel Global Healthcare Strategy
- David Sayen, Regional Administrator of the Centers for Medicare & Medicaid Services
- Dr. Deborah Dean, Founder and Executive Director, Children's Global Health Initiative
- Don Ross, co-founder of HealthTech Capital, Board Director of Sand Hill Angels
- Dong-Su Kim, Director of Investment at Samsung Ventures America
- Geoffrey Clapp, Mentor and Advisor, Pipette, Lumoback, and more
- Jafar Shenasa, Director, Regulatory Affairs at Proteus Digital Health
- Dr. James Kahn, Chief of Medical Services VA Palo Alto Health Care System, Professor & Vice-Chair Department of Medicine, Stanford
- Josh Nesbit, Chief Executive Officer, Medic Mobile
- Dr. Leslie Saxon, Chief, Division of Cardiovascular Medicine, USC Keck School of Medicine & Executive Director of USC Center for Body Computing
- Leslie Ziegler, Chief Evangelist & Creative Director. Rock Health
- Lisa Suennen, Co-Founder and Managing Member of Psilos Group (VC firm)
- Manu Prakash, Assistant Professor, Bioengineering, Stanford University
- Margaret Laws, Director, Innovations for the Underserved, CHCF
- Mark Zdeblick, Chief Technology Officer, Proteus Digital Health
- Matthew Douglass, Co-Founder and VP of Engineering, Practice Fusion
- Monique Lambert, Medical Ethnographer, Investigator, Palo Alto Medical Foundation
- Rob Lister, Director of Design, AT&T Foundry
- Sarah Pollet, Chief Operating Officer, Rock Health
- Sonny Vu, CEO & Founder, Misfit Wearables
| Quarters | Fall |
|---|---|
| Course Number | Bioe 273 |
| Cross-listings | Med 273 |
| Day, Time | Wednesday 5:15 – 7:00 pm |
| Content | Mobile Health Technology |
| Course Directors | Paul Yock, M.D., Paul Wang, M.D., and Marta Gaia Zanchi, Ph.D and guest lecturers |
| Location | Li Ka Shing Center, 291 Campus Drive, Lecture Hall LK120, Stanford University |
| Units | 1 unit; Credit/No Credit |
| Schools | Engineering/ Medicine |
Course Structure and Calendar
- September 26
- Introduction
- October 3
- Applications
- October 10
- Enabling Technologies
- October 17
- Innovation for the Consumer
- October 24
- Innovation for the Enterprise
- October 31
- Policy
- November 7
- Money: Business Models and Financing
- November 14
- Beyond US: Global Mobile Health
- November 28
- Entrepreneurship
- December 5
- Future Trends
About Marta Zanchi
Marta Gaia Zanchi is principal consultant at Medinnovo, which she founded in 2011 with 10 years combined experience studying and working in the medical device field and in the semiconductors and wireless communications field.
Dr. Zanchi is also founder and co-chair of the Connected Health Safety Initiative, a non-profit initiative whose goal is to develop a framework for collaborative management of safety, clinical effectiveness, and continuous availability of care in connected healthcare systems. She is also a a mentor at StartX, a student start-up accelerator designed and developed to provide a premier entrepreneurial experience for Stanford students, and a resident with The Angels Forum, where she helps identify and screen life science companies and learns the fundamentals of the angel funding process.
Prior to founding Medinnovo, she was a consultant for the Nuclear and Cardiac divisions of a clinical institution in Italy, a system design engineer for a semiconductor company in Fremont, CA, and a researcher developing new medical technologies in partnership with organizations in Italy, Canada, and the United States. More recently, she worked as a product management professional with the business development group of a then privately held wireless technology company in Sunnyvale, California, where she was responsible for bridging across different functional aspects of the company to develop new products and product positioning.
During her PhD studies, Dr. Zanchi was a Medical Device Fellow, Reviewer and Electrical Engineer with the U.S. Food and Drug Administration (FDA). Here she reviewed 510(k) applications with the Office of Device Evaluation, and researched on the electromagnetic effects of magnetic resonance imaging with the Office of Science and Engineering Laboratory. From August 2010 to December 2011, she applied her expertise on regulation working with the Stanford University and Northwestern University research team on the InHealth study "A Comprehensive Analysis of the FDA 510(k) Process," led by investigators John Linehan, PhD, and Jan Pietzsch, PhD. The results of the study were first announced in Washington D.C. in May, at a National Press Club Conference attended by Dr. Jeffrey Shuren, head of the FDA's medical device arm.
Dr. Zanchi is a top graduate in biomedical engineering and electrical engineering from Politecnico Di Milano (Italy) and Stanford University. Her work at both universities focused on the development of innovative medical devices and systems for the diagnosis and staging of diseases, which led to several scientific publications, two research grants, and a patent on a novel radiofrequency control feedback techniques in Magnetic Resonance Imaging. She was awarded the Politecnico Di Milano's highest student honor and two fellowships from Stanford University, by the Electrical Engineering Department and the Stanford Biodesign program. She holds a certificate in entrepreneurship and an award from the Stanford Graduate School of Business in Stanford University.